Institute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, People's Republic of China. Fujian Provincial Key Laboratory of Biochemical Technology, Xiamen 361021, People's Republic of China.
Biofabrication. 2017 Aug 3;9(3):032002. doi: 10.1088/1758-5090/aa8113.
Fabrication of tissue-/organ-like structures at arbitrary geometries by mimicking the properties of the complex material offers enormous interest to the research and clinical applicability in cardiovascular diseases. Patient-specific, durable, and realistic three-dimensional (3D) cardiac models for anatomic consideration have been developed for education, pro-surgery planning, and intra-surgery guidance. In cardiac tissue engineering (TE), 3D printing technology is the most convenient and efficient microfabrication method to create biomimetic cardiovascular tissue for the potential in vivo implantation. Although booming rapidly, this technology is still in its infancy. Herein, we provide an emphasis on the application of this technology in clinical practices, micro- and nanoscale fabrications by cardiac TE. Initially, we will give an overview on the fabrication methods that can be used to synthesize the arbitrary 3D components with controlled features and will subsequently highlight the current limitations and future perspective of 3D printing used for cardiovascular diseases.
通过模拟复杂材料的特性来制造具有任意几何形状的组织/器官样结构,这对心血管疾病的研究和临床应用具有巨大的兴趣。已经开发出了用于解剖学考虑的特定于患者的、持久的和现实的三维(3D)心脏模型,用于教育、手术前规划和手术内指导。在心脏组织工程(TE)中,3D 打印技术是创建用于潜在体内植入的仿生心血管组织的最方便和高效的微制造方法。尽管这项技术发展迅速,但仍处于起步阶段。在这里,我们重点介绍该技术在心脏 TE 的临床实践、微观和纳米级制造中的应用。首先,我们将概述可用于合成具有可控特征的任意 3D 组件的制造方法,随后将重点介绍用于心血管疾病的 3D 打印的当前局限性和未来展望。